ARTICLE | Company News
Enzon, NatImmune deal
October 10, 2005 7:00 AM UTC
NatImmune granted ENZN exclusive worldwide rights, excluding Nordic countries, to recombinant human mannan-binding lectin (rhMBL) to prevent severe infections in MBL-deficient persons undergoing chem...